APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Meropenem Injection Market Outlook and Growth Opportunities 2026

2 January 2026203 pages

Choose your research edition.

Industry ResearchMeropenem Injection Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Injection Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Meropenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Injection Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Meropenem Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Meropenem Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Meropenem Injection market include Chongqin Shenghuaxi, Zhejiang Hisun Pharmaceutical, Xinya Pharm, CSPC Group, Shenzhen Haibin Pharmaceutical, Sandoz, Mylan, Luoxin Pharmaceutical and United Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meropenem Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meropenem Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meropenem Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meropenem Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Meropenem Injection Segment by Company

Chongqin Shenghuaxi

Zhejiang Hisun Pharmaceutical

Xinya Pharm

CSPC Group

Shenzhen Haibin Pharmaceutical

Sandoz

Mylan

Luoxin Pharmaceutical

United Laboratories

Pfizer

Hainan Haiyao Co., Ltd.

Fresenius Kabi

PKU HealthCare

Sumitomo Dainippon Pharma

Sagent Pharmaceuticals

Macleods Pharmaceuticals

Johnlee Pharmaceuticals

Bionova Scientific

AuroMedics

Amneal Pharmaceuticals

Meropenem Injection Segment by Type

0.25g/vial

0.5g/vial

1g/vial

Meropenem Injection Segment by Application

Hospital

Clinics

Others

Meropenem Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Meropenem Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Meropenem Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Meropenem Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Meropenem Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meropenem Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Meropenem Injection industry.

Chapter 3: Detailed analysis of Meropenem Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Meropenem Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Meropenem Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Meropenem Injection Industry Trends Table 2. Meropenem Injection Industry Drivers Table 3. Meropenem Injection Industry Opportunities and Challenges Table 4. Meropenem Injection Industry Restraints Table 5. Global Meropenem Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Meropenem Injection Revenue Share by Company (2021-2026) Table 7. Global Meropenem Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Meropenem Injection Sales Volume Share by Company (2021-2026) Table 9. Global Meropenem Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Meropenem Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Meropenem Injection Key Company Manufacturing Base & Headquarters Table 12. Global Meropenem Injection Company, Product Type & Application Table 13. Global Meropenem Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Meropenem Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.25g/vial Table 18. Significant Companies of 0.5g/vial Table 19. Significant Companies of 1g/vial Table 20. Global Meropenem Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Meropenem Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Meropenem Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Meropenem Injection Sales Volume Share by Type (2021-2026) Table 24. Global Meropenem Injection Sales Volume Share by Type (2027-2032) Table 25. Global Meropenem Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Meropenem Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Meropenem Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Meropenem Injection Sales Value Share by Type (2021-2026) Table 29. Global Meropenem Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Meropenem Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Meropenem Injection Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Meropenem Injection Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Meropenem Injection Sales Volume Share by Application (2021-2026) Table 37. Global Meropenem Injection Sales Volume Share by Application (2027-2032) Table 38. Global Meropenem Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Meropenem Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Meropenem Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Meropenem Injection Sales Value Share by Application (2021-2026) Table 42. Global Meropenem Injection Sales Value Share by Application (2027-2032) Table 43. Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Meropenem Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Meropenem Injection Sales Market Share by Region (2021-2026) Table 46. Global Meropenem Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Meropenem Injection Sales Market Share by Region (2027-2032) Table 48. Global Meropenem Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Meropenem Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Meropenem Injection Sales Value Share by Region (2021-2026) Table 51. Global Meropenem Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Meropenem Injection Sales Value Share by Region (2027-2032) Table 53. Global Meropenem Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Meropenem Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Meropenem Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Meropenem Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 58. Global Meropenem Injection Sales Market Share by Country (2021-2026) Table 59. Global Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Meropenem Injection Sales Market Share by Country (2027-2032) Table 61. Global Meropenem Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Meropenem Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Meropenem Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Meropenem Injection Sales Value Market Share by Country (2027-2032) Table 65. Chongqin Shenghuaxi Company Information Table 66. Chongqin Shenghuaxi Business Overview Table 67. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Chongqin Shenghuaxi Meropenem Injection Product Portfolio Table 69. Chongqin Shenghuaxi Recent Development Table 70. Zhejiang Hisun Pharmaceutical Company Information Table 71. Zhejiang Hisun Pharmaceutical Business Overview Table 72. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio Table 74. Zhejiang Hisun Pharmaceutical Recent Development Table 75. Xinya Pharm Company Information Table 76. Xinya Pharm Business Overview Table 77. Xinya Pharm Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Xinya Pharm Meropenem Injection Product Portfolio Table 79. Xinya Pharm Recent Development Table 80. CSPC Group Company Information Table 81. CSPC Group Business Overview Table 82. CSPC Group Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. CSPC Group Meropenem Injection Product Portfolio Table 84. CSPC Group Recent Development Table 85. Shenzhen Haibin Pharmaceutical Company Information Table 86. Shenzhen Haibin Pharmaceutical Business Overview Table 87. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio Table 89. Shenzhen Haibin Pharmaceutical Recent Development Table 90. Sandoz Company Information Table 91. Sandoz Business Overview Table 92. Sandoz Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sandoz Meropenem Injection Product Portfolio Table 94. Sandoz Recent Development Table 95. Mylan Company Information Table 96. Mylan Business Overview Table 97. Mylan Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Mylan Meropenem Injection Product Portfolio Table 99. Mylan Recent Development Table 100. Luoxin Pharmaceutical Company Information Table 101. Luoxin Pharmaceutical Business Overview Table 102. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Luoxin Pharmaceutical Meropenem Injection Product Portfolio Table 104. Luoxin Pharmaceutical Recent Development Table 105. United Laboratories Company Information Table 106. United Laboratories Business Overview Table 107. United Laboratories Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. United Laboratories Meropenem Injection Product Portfolio Table 109. United Laboratories Recent Development Table 110. Pfizer Company Information Table 111. Pfizer Business Overview Table 112. Pfizer Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Pfizer Meropenem Injection Product Portfolio Table 114. Pfizer Recent Development Table 115. Hainan Haiyao Co., Ltd. Company Information Table 116. Hainan Haiyao Co., Ltd. Business Overview Table 117. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio Table 119. Hainan Haiyao Co., Ltd. Recent Development Table 120. Fresenius Kabi Company Information Table 121. Fresenius Kabi Business Overview Table 122. Fresenius Kabi Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Fresenius Kabi Meropenem Injection Product Portfolio Table 124. Fresenius Kabi Recent Development Table 125. PKU HealthCare Company Information Table 126. PKU HealthCare Business Overview Table 127. PKU HealthCare Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. PKU HealthCare Meropenem Injection Product Portfolio Table 129. PKU HealthCare Recent Development Table 130. Sumitomo Dainippon Pharma Company Information Table 131. Sumitomo Dainippon Pharma Business Overview Table 132. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio Table 134. Sumitomo Dainippon Pharma Recent Development Table 135. Sagent Pharmaceuticals Company Information Table 136. Sagent Pharmaceuticals Business Overview Table 137. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Sagent Pharmaceuticals Meropenem Injection Product Portfolio Table 139. Sagent Pharmaceuticals Recent Development Table 140. Macleods Pharmaceuticals Company Information Table 141. Macleods Pharmaceuticals Business Overview Table 142. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Macleods Pharmaceuticals Meropenem Injection Product Portfolio Table 144. Macleods Pharmaceuticals Recent Development Table 145. Johnlee Pharmaceuticals Company Information Table 146. Johnlee Pharmaceuticals Business Overview Table 147. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Johnlee Pharmaceuticals Meropenem Injection Product Portfolio Table 149. Johnlee Pharmaceuticals Recent Development Table 150. Bionova Scientific Company Information Table 151. Bionova Scientific Business Overview Table 152. Bionova Scientific Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Bionova Scientific Meropenem Injection Product Portfolio Table 154. Bionova Scientific Recent Development Table 155. AuroMedics Company Information Table 156. AuroMedics Business Overview Table 157. AuroMedics Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. AuroMedics Meropenem Injection Product Portfolio Table 159. AuroMedics Recent Development Table 160. Amneal Pharmaceuticals Company Information Table 161. Amneal Pharmaceuticals Business Overview Table 162. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Amneal Pharmaceuticals Meropenem Injection Product Portfolio Table 164. Amneal Pharmaceuticals Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Meropenem Injection Distributors List Table 168. Meropenem Injection Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Meropenem Injection Product Image Figure 2. Global Meropenem Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Meropenem Injection Sales (2021-2032) & (K Units) Figure 5. Global Meropenem Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Meropenem Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.25g/vial Image Figure 10. 0.5g/vial Image Figure 11. 1g/vial Image Figure 12. Global Meropenem Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Meropenem Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Meropenem Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Meropenem Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Meropenem Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Meropenem Injection Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Meropenem Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Meropenem Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Meropenem Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Meropenem Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Meropenem Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Meropenem Injection Sales Value Share by Application (2021-2032) Figure 27. Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Meropenem Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Meropenem Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Meropenem Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Meropenem Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Meropenem Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Meropenem Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Meropenem Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Meropenem Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Meropenem Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Meropenem Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Meropenem Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Meropenem Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Meropenem Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Meropenem Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g/vial
  • 0.5g/vial
  • 1g/vial
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Chongqin Shenghuaxi
  • Zhejiang Hisun Pharmaceutical
  • Xinya Pharm
  • CSPC Group
  • Shenzhen Haibin Pharmaceutical
  • Sandoz
  • Mylan
  • Luoxin Pharmaceutical
  • United Laboratories
  • Pfizer
  • Hainan Haiyao Co., Ltd.
  • Fresenius Kabi
  • PKU HealthCare
  • Sumitomo Dainippon Pharma
  • Sagent Pharmaceuticals
  • Macleods Pharmaceuticals
  • Johnlee Pharmaceuticals
  • Bionova Scientific
  • AuroMedics
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meropenem Injection Sales Value (2021-2032)
  4. 1.2.2 Global Meropenem Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Meropenem Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Meropenem Injection Market Dynamics
  1. 2.1 Meropenem Injection Industry Trends
  2. 2.2 Meropenem Injection Industry Drivers
  3. 2.3 Meropenem Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Injection Industry Restraints
3 Meropenem Injection Market by Company
  1. 3.1 Global Meropenem Injection Company Revenue Ranking in 2025
  2. 3.2 Global Meropenem Injection Revenue by Company (2021-2026)
  3. 3.3 Global Meropenem Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Meropenem Injection Average Price by Company (2021-2026)
  5. 3.5 Global Meropenem Injection Company Ranking (2024-2026)
  6. 3.6 Global Meropenem Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Meropenem Injection Company Product Type and Application
  8. 3.8 Global Meropenem Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Meropenem Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Meropenem Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Meropenem Injection Market by Type
  1. 4.1 Meropenem Injection Type Introduction
  2. 4.1.1 0.25g/vial
  3. 4.1.2 0.5g/vial
  4. 4.1.3 1g/vial
  5. 4.2 Global Meropenem Injection Sales Volume by Type
  6. 4.2.1 Global Meropenem Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meropenem Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Meropenem Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Meropenem Injection Sales Value by Type
  10. 4.3.1 Global Meropenem Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meropenem Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Meropenem Injection Sales Value Share by Type (2021-2032)
5 Meropenem Injection Market by Application
  1. 5.1 Meropenem Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Meropenem Injection Sales Volume by Application
  6. 5.2.1 Global Meropenem Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meropenem Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Meropenem Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Meropenem Injection Sales Value by Application
  10. 5.3.1 Global Meropenem Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Meropenem Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Meropenem Injection Sales Value Share by Application (2021-2032)
6 Meropenem Injection Regional Sales and Value Analysis
  1. 6.1 Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meropenem Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Meropenem Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Meropenem Injection Sales by Region (2027-2032)
  5. 6.3 Global Meropenem Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Meropenem Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Meropenem Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Meropenem Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Meropenem Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Meropenem Injection Sales Value (2021-2032)
  12. 6.6.2 North America Meropenem Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Meropenem Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Meropenem Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Meropenem Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Meropenem Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Meropenem Injection Sales Value (2021-2032)
  21. 6.9.2 South America Meropenem Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Meropenem Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Meropenem Injection Sales Value Share by Country, 2025 VS 2032
7 Meropenem Injection Country-level Sales and Value Analysis
  1. 7.1 Global Meropenem Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Meropenem Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Meropenem Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Meropenem Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Meropenem Injection Sales by Country (2027-2032)
  6. 7.4 Global Meropenem Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Meropenem Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Meropenem Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Meropenem Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Meropenem Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Meropenem Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Meropenem Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Meropenem Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Meropenem Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Meropenem Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Meropenem Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Meropenem Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Meropenem Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Meropenem Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Meropenem Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Meropenem Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Meropenem Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Meropenem Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Meropenem Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Meropenem Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Meropenem Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Meropenem Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Meropenem Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Meropenem Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Meropenem Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Meropenem Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Meropenem Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Meropenem Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Meropenem Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Meropenem Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Meropenem Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Meropenem Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Meropenem Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Meropenem Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqin Shenghuaxi
  2. 8.1.1 Chongqin Shenghuaxi Company Information
  3. 8.1.2 Chongqin Shenghuaxi Business Overview
  4. 8.1.3 Chongqin Shenghuaxi Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
  6. 8.1.5 Chongqin Shenghuaxi Recent Developments
  7. 8.2 Zhejiang Hisun Pharmaceutical
  8. 8.2.1 Zhejiang Hisun Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Hisun Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
  12. 8.2.5 Zhejiang Hisun Pharmaceutical Recent Developments
  13. 8.3 Xinya Pharm
  14. 8.3.1 Xinya Pharm Company Information
  15. 8.3.2 Xinya Pharm Business Overview
  16. 8.3.3 Xinya Pharm Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xinya Pharm Meropenem Injection Product Portfolio
  18. 8.3.5 Xinya Pharm Recent Developments
  19. 8.4 CSPC Group
  20. 8.4.1 CSPC Group Company Information
  21. 8.4.2 CSPC Group Business Overview
  22. 8.4.3 CSPC Group Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CSPC Group Meropenem Injection Product Portfolio
  24. 8.4.5 CSPC Group Recent Developments
  25. 8.5 Shenzhen Haibin Pharmaceutical
  26. 8.5.1 Shenzhen Haibin Pharmaceutical Company Information
  27. 8.5.2 Shenzhen Haibin Pharmaceutical Business Overview
  28. 8.5.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
  30. 8.5.5 Shenzhen Haibin Pharmaceutical Recent Developments
  31. 8.6 Sandoz
  32. 8.6.1 Sandoz Company Information
  33. 8.6.2 Sandoz Business Overview
  34. 8.6.3 Sandoz Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz Meropenem Injection Product Portfolio
  36. 8.6.5 Sandoz Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Meropenem Injection Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Luoxin Pharmaceutical
  44. 8.8.1 Luoxin Pharmaceutical Company Information
  45. 8.8.2 Luoxin Pharmaceutical Business Overview
  46. 8.8.3 Luoxin Pharmaceutical Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
  48. 8.8.5 Luoxin Pharmaceutical Recent Developments
  49. 8.9 United Laboratories
  50. 8.9.1 United Laboratories Company Information
  51. 8.9.2 United Laboratories Business Overview
  52. 8.9.3 United Laboratories Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 United Laboratories Meropenem Injection Product Portfolio
  54. 8.9.5 United Laboratories Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Meropenem Injection Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Hainan Haiyao Co., Ltd.
  62. 8.11.1 Hainan Haiyao Co., Ltd. Company Information
  63. 8.11.2 Hainan Haiyao Co., Ltd. Business Overview
  64. 8.11.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
  66. 8.11.5 Hainan Haiyao Co., Ltd. Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Meropenem Injection Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 PKU HealthCare
  74. 8.13.1 PKU HealthCare Company Information
  75. 8.13.2 PKU HealthCare Business Overview
  76. 8.13.3 PKU HealthCare Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 PKU HealthCare Meropenem Injection Product Portfolio
  78. 8.13.5 PKU HealthCare Recent Developments
  79. 8.14 Sumitomo Dainippon Pharma
  80. 8.14.1 Sumitomo Dainippon Pharma Company Information
  81. 8.14.2 Sumitomo Dainippon Pharma Business Overview
  82. 8.14.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
  84. 8.14.5 Sumitomo Dainippon Pharma Recent Developments
  85. 8.15 Sagent Pharmaceuticals
  86. 8.15.1 Sagent Pharmaceuticals Company Information
  87. 8.15.2 Sagent Pharmaceuticals Business Overview
  88. 8.15.3 Sagent Pharmaceuticals Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
  90. 8.15.5 Sagent Pharmaceuticals Recent Developments
  91. 8.16 Macleods Pharmaceuticals
  92. 8.16.1 Macleods Pharmaceuticals Company Information
  93. 8.16.2 Macleods Pharmaceuticals Business Overview
  94. 8.16.3 Macleods Pharmaceuticals Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
  96. 8.16.5 Macleods Pharmaceuticals Recent Developments
  97. 8.17 Johnlee Pharmaceuticals
  98. 8.17.1 Johnlee Pharmaceuticals Company Information
  99. 8.17.2 Johnlee Pharmaceuticals Business Overview
  100. 8.17.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
  102. 8.17.5 Johnlee Pharmaceuticals Recent Developments
  103. 8.18 Bionova Scientific
  104. 8.18.1 Bionova Scientific Company Information
  105. 8.18.2 Bionova Scientific Business Overview
  106. 8.18.3 Bionova Scientific Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Bionova Scientific Meropenem Injection Product Portfolio
  108. 8.18.5 Bionova Scientific Recent Developments
  109. 8.19 AuroMedics
  110. 8.19.1 AuroMedics Company Information
  111. 8.19.2 AuroMedics Business Overview
  112. 8.19.3 AuroMedics Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 AuroMedics Meropenem Injection Product Portfolio
  114. 8.19.5 AuroMedics Recent Developments
  115. 8.20 Amneal Pharmaceuticals
  116. 8.20.1 Amneal Pharmaceuticals Company Information
  117. 8.20.2 Amneal Pharmaceuticals Business Overview
  118. 8.20.3 Amneal Pharmaceuticals Meropenem Injection Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meropenem Injection Value Chain Analysis
  2. 9.1.1 Meropenem Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meropenem Injection Sales Mode & Process
  6. 9.2 Meropenem Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meropenem Injection Distributors
  9. 9.2.3 Meropenem Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst